Professional Seasonal Analysis for Trading

Zentalis Pharmaceuticals, Inc. - common stock (ZNTL)

Seasonality Analysis

Stocks 7 Years Analyzed

Zentalis Pharmaceuticals, Inc. - common stock Annual Seasonality Statistics

2.65%
Avg Annual Return
46.2%
Avg Monthly Win Rate
6/12
Positive Months
7
Years Analyzed

Zentalis Pharmaceuticals, Inc. - common stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -5.48%
33%
Very Weak
February 3.71%
50%
Weak
March -5.63%
33%
Very Weak
April 5.88%
71%
Very Strong
May BEST 9.37%
50%
Weak
June WORST -8.06%
33%
Very Weak
July -3.46%
50%
Weak
August 7.66%
50%
Weak
September -7.45%
33%
Very Weak
October 2.32%
50%
Weak
November -0.42%
50%
Weak
December 4.22%
50%
Weak

Zentalis Pharmaceuticals, Inc. - common stock 2026 vs Historical Pattern

Current Position
53.16
Historical Avg Position
38.86
Deviation
+14.3
Performance
Significantly Above Average

Zentalis Pharmaceuticals, Inc. - common stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ZNTL with overlay patterns, custom date ranges, and more.

Create Free Account

Zentalis Pharmaceuticals, Inc. - common stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Zentalis Pharmaceuticals, Inc. - common stock Seasonal Historical Performance

Historical Performance

See historical average returns for ZNTL across multiple timeframes.

Create Free Account

About Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) Seasonality

Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) has been analyzed using 7 years of historical data to identify seasonal patterns. Classified under Stocks, Zentalis Pharmaceuticals, Inc. - common stock shows distinct seasonal tendencies based on historical data.

The strongest month for Zentalis Pharmaceuticals, Inc. - common stock is historically May, with an average return of 9.37% and a win rate of 50%. Conversely, June tends to be the weakest month, averaging -8.06% return.

Looking at the full calendar year, Zentalis Pharmaceuticals, Inc. - common stock has an average annual return of 2.65% with an overall monthly win rate of 46.2%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Zentalis Pharmaceuticals, Inc. - common stock has a consistency score of 32.3 (Poor), based on 7 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Zentalis Pharmaceuticals, Inc. - common stock Seasonality FAQ

What is the best month to buy Zentalis Pharmaceuticals, Inc. - common stock (ZNTL)?

Historically, May has been the best month for Zentalis Pharmaceuticals, Inc. - common stock, with an average return of 9.37% and a win rate of 50%. However, past performance does not guarantee future results.

What is the worst month for Zentalis Pharmaceuticals, Inc. - common stock (ZNTL)?

Based on historical data, June has been the weakest month for Zentalis Pharmaceuticals, Inc. - common stock, with an average return of -8.06%. This is a historical observation and does not guarantee future results.

How reliable is ZNTL seasonality data?

The seasonality analysis for Zentalis Pharmaceuticals, Inc. - common stock is based on 7 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Zentalis Pharmaceuticals, Inc. - common stock seasonality in my trading?

Use Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.